When tumours reached 0.5 cm in diameter, at approximately the 7th day after tumour implantation, mice (n = 3 each) were treated with 0.2 ml (50 μg) of Cd137l-Fc fusion proteins or control mock-Fc by intraperitoneal injection for 3 consecutive days. This evidence concerns the gene TNFSF9 and neoplasm.